CHRISTINA BALDIGA: Open Payments
NPI 1427306877 · DERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 14 payments from 10 companies in 2025. Trend: 2023 $330 · 2024 $446 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Lundbeck LLC | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $29 |
| Luye Pharma (USA) Ltd. | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, UZEDY, CAPLYTA, Auvelity, VRAYLAR, ERZOFRI EXTENDED-RELEASE.
Industry payments across NH — which companies pay providers there.
